An Update on Childhood-Onset Takayasu Arteritis

Area of Science:

• Rheumatology
• Pediatric Vasculitis
• Immunology

Background:

• Takayasu Arteritis (TAK) is a rare large vessel vasculitis affecting the aorta and its branches.
• Clinical manifestations are heterogeneous, severe, and result from inflammation and ischemia.
• Disease flares cause cumulative damage, leading to significant morbidity and mortality.

Purpose of the Study:

• To provide a comprehensive review of childhood-onset Takayasu Arteritis.
• To focus on recent publications and advancements in understanding and managing pediatric TAK.
• To highlight the challenges and current therapeutic approaches in pediatric large vessel vasculitis.

Main Methods:

• Review of recent scientific literature on childhood-onset Takayasu Arteritis.
• Analysis of current understanding of TAK pathogenesis.
• Evaluation of emerging therapeutic strategies, including biologic agents.

Main Results:

• Newer understanding of TAK pathogenesis has led to targeted therapies like TNFα- and IL-6 inhibitors.
• These agents have shown improved disease control in some patients.
• Long-term data, particularly in children, are still limited, and prognosis remains guarded.

Conclusions:

• Childhood-onset TAK presents a significant disease burden with guarded prognosis.
• Targeted biologic therapies offer improved disease control but require further long-term evaluation in pediatric populations.
• Comprehensive review underscores the need for continued research in pediatric Takayasu Arteritis management.